A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, ...
Trends in preferred place of death for prostate cancer in the United States from 2003 to 2020: Analysis of CDC WONDER database. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary ...
Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately, prostate cancer cells adapt ...
Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer Patients with newly diagnosed LPCa with Gleason score ≤ 7, clinical stage T1b to T3a, and prostate-specific antigen < 30 ng/mL were ...
Researchers have unveiled important new insights into how hormones known as androgens act on our cells - and the discovery could boost efforts to develop better treatments for prostate, ovarian and ...
The androgen receptor is the primary driver of the initiation and growth of prostate cancer, the second-leading cause of death in men. Looking to have a better understanding of how the androgen ...
Researchers have created an epigenetic tool which has implications for medicine, sports, and agriculture. Researchers from the University of Otago -- Ōtākou Whakaihu Waka have created a world-first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results